Expression and characterization of wild type and mutant recombinant human sulfamidase - Implications for Sanfilippo (mucopolysaccharidosis IIIA) syndrome
dc.contributor.author | Perkins, K. | |
dc.contributor.author | Byers, S. | |
dc.contributor.author | Yogalingam, G. | |
dc.contributor.author | Weber, B. | |
dc.contributor.author | Hopwood, J. | |
dc.date.issued | 1999 | |
dc.description.abstract | Mucopolysaccharidosis IIIA (MPS-IIIA) is an autosomal recessive lysosomal storage disorder caused by the deficiency of sulfamidase (NS; EC 3.10.1.1), resulting in defective degradation and storage of heparan sulfate. This paper reports the production and characterization of monoclonal and polyclonal antibodies against recombinant human sulfamidase (rhNS) to quantitate and characterize normal and mutant sulfamidase produced from the wild type NS expression vector. Glycosylation and phosphorylation studies of immunoprecipitated rhNS show that all five potential glycosylation sites are utilized, with three high mannose/hybrid oligosaccharides and two simpler chains, with at least one functional mannose 6-phosphate group. An NS quantification system was developed to determine the effect of the three most common and severe patient mutations: S66W (Italy), R74C (Poland), and R245H (The Netherlands). The quantity and specific activity of expressed mutant rhNS was significantly lower than expressed normal rhNS, with 0.3, 0.2, and 0.05% of normal rhNS produced and 15, 17, and 83% of normal specific activity for S66W, R74C, and R245H observed, respectively. The recent structural elucidation of N-acetylgalactosamine-4-sulfatase was utilized to postulate the effect on the structure-function relationship of NS. The characterization of normal and mutated rhNS has relevance for efficient diagnosis and therapeutic developments for MPS-IIIA patients. | |
dc.identifier.citation | Journal of Biological Chemistry, 1999; 274(52):37193-37199 | |
dc.identifier.doi | 10.1074/jbc.274.52.37193 | |
dc.identifier.issn | 0021-9258 | |
dc.identifier.issn | 1083-351X | |
dc.identifier.orcid | Byers, S. [0000-0001-5576-3636] | |
dc.identifier.uri | http://hdl.handle.net/2440/7443 | |
dc.language.iso | en | |
dc.publisher | AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC | |
dc.source.uri | https://doi.org/10.1074/jbc.274.52.37193 | |
dc.subject | CHO Cells | |
dc.subject | Animals | |
dc.subject | Humans | |
dc.subject | Mucopolysaccharidosis III | |
dc.subject | Hydrolases | |
dc.subject | Recombinant Proteins | |
dc.subject | Glycosylation | |
dc.subject | Phosphorylation | |
dc.subject | Phenotype | |
dc.subject | Mutation | |
dc.subject | Cricetinae | |
dc.title | Expression and characterization of wild type and mutant recombinant human sulfamidase - Implications for Sanfilippo (mucopolysaccharidosis IIIA) syndrome | |
dc.type | Journal article | |
pubs.publication-status | Published |